Results 91 to 100 of about 1,195,181 (317)

Fish Commission research briefs. Vol. 2, no. 2

open access: yes
These short reports are intended to inform the public, industry, and other interested parties of the current studies of the Commission's staff and the basis for conservation measures.
Oregon. Fish Commission
core  

Ponds, pond fish, and pond fish culture Kansas Fish and Game Bulletin, No. 01 Part 1.

open access: yes, 1910
"November, 1910."Kansas Forestry Fish and Game Bulletin, No. 1 Part 1Part I. On ponds.--Part II. On pond fish.--Part III.
Kansas State Fish and Game Warden
core  

Interaction of HS1BP3 with cortactin modulates TKS5 localisation, cell secretion and cancer malignancy

open access: yesMolecular Oncology, EarlyView.
Here, we demonstrate that HS1BP3 interacts with Cortactin through a proline‐rich region (PRR3.1) and show that this interaction, and HS1BP3 itself, promote cancer cell proliferation and invasion. Inhibition of this interaction leads to build‐up of TKS5 in multivesicular endosomes and altered secretion of CD63 and CD9, providing an explanation for the ...
Arja Arnesen Løchen   +9 more
wiley   +1 more source

Fish Commission research briefs. Vol. 4, no. 1

open access: yes
These short reports are intended to inform the public, industry, and other interested parties of the current studies of the Commission's staff and of the basis for conservation measures.
Oregon. Fish Commission
core  

Ponds, pond fish, and pond fish culture Kansas Fish and Game Bulletin No. 01 Part 2

open access: yes, 1911
"July, 1911."Kansas Forestry Fish and Game Bulletin, No. 01 Part 2Part I. On ponds.--Part II. On pond fish.--Part III.
Kansas State Fish and Game Warden
core  

Proteasome inhibitor, ixazomib prevents topoisomerase‐I degradation and reverses irinotecan resistance in colorectal cancer

open access: yesMolecular Oncology, EarlyView.
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata   +10 more
wiley   +1 more source

Fish Commission research briefs. Vol. 2, no. 1

open access: yes
These short reports are intended to inform the public, industry, and other interested parties of the current studies of the Commission's staff and the basis for conservation measures.
Oregon. Fish Commission
core  

Circulating tumor cell viability during and after radiotherapy mirrors treatment response in cancer patients

open access: yesMolecular Oncology, EarlyView.
Radiotherapy (RT) response depends on the DNA repair capacity of tumor and host cells. We show that circulating tumor cell (CTC) counts and apoptosis rates before and after RT predict treatment response and outcome, which can be accessed via easily accessible liquid biopsy approaches. Created in BioRender. Wikman, H.
Yvonne Goy   +10 more
wiley   +1 more source

Advancing Energy Sovereignty and Economic Prosperity for First Nations through Green Energy Statecraft

open access: yesCosmopolitan Civil Societies: An Interdisciplinary Journal
A new approach to energy transition governance is necessary, one that is inclusive of First Nations on whose land the energy transition will occur.
Adam Fish, Elizabeth Thurbon
doaj   +1 more source

Home - About - Disclaimer - Privacy